TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT00756496

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mammography screening and diagnosis
Description: Mammography screening and diagnosis
Study: NCT04720586

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: lower eyelid blepharoplasty , retractor plication and wedge resection
Description: combined lower eyelid blepharoplasty , retractor plication and wedge resection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: lower eyelid blepharoplasty , retractor plication and wedge resection
Description: combined lower eyelid blepharoplasty , retractor plication and wedge resection

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: lower eyelid blepharoplasty and retractor plication
Description: combined lower eyelid blepharoplasty and retractor plication procedures

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: lower eyelid blepharoplasty and retractor plication
Description: combined lower eyelid blepharoplasty and retractor plication procedures
Study: NCT04599205

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: fractional co2 laser, microneedling and topical tranexamic acid gel

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: fractional co2 laser, microneedling and topical tranexamic acid gel
Study: NCT03048370

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Left body temperature VS
Description: Caloric vestibular stimulation (CVS), which involves the irrigation of cold or warm water into the external ear canal, induces a temperature gradient across the semicircular canals of the vestibular apparatus stimulating the vestibular nerve. It is commonly used in both otolaryngology to assess vestibular function and neurology to test brain stem function
Study: NCT04599205

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: fractional co2 laser, microneedling and topical tranexamic acid gel
Study: NCT04838106

Intervention type: OTHER
Intervention: Not applicable as observational study
Description: Not applicable as observational study.

Intervention type: OTHER
Intervention: Not applicable as observational study
Description: Not applicable as observational study.
Study: NCT03048370

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Right body temperature VS
Description: Caloric vestibular stimulation (CVS), which involves the irrigation of cold or warm water into the external ear canal, induces a temperature gradient across the semicircular canals of the vestibular apparatus stimulating the vestibular nerve. It is commonly used in both otolaryngology to assess vestibular function and neurology to test brain stem function

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Left warm CVS
Description: Caloric vestibular stimulation (CVS), which involves the irrigation of cold or warm water into the external ear canal, induces a temperature gradient across the semicircular canals of the vestibular apparatus stimulating the vestibular nerve. It is commonly used in both otolaryngology to assess vestibular function and neurology to test brain stem function

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Right warm CVS
Description: Caloric vestibular stimulation (CVS), which involves the irrigation of cold or warm water into the external ear canal, induces a temperature gradient across the semicircular canals of the vestibular apparatus stimulating the vestibular nerve. It is commonly used in both otolaryngology to assess vestibular function and neurology to test brain stem function

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Left cold CVS
Description: Caloric vestibular stimulation (CVS), which involves the irrigation of cold or warm water into the external ear canal, induces a temperature gradient across the semicircular canals of the vestibular apparatus stimulating the vestibular nerve. It is commonly used in both otolaryngology to assess vestibular function and neurology to test brain stem function

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Right cold CVS
Description: Caloric vestibular stimulation (CVS), which involves the irrigation of cold or warm water into the external ear canal, induces a temperature gradient across the semicircular canals of the vestibular apparatus stimulating the vestibular nerve. It is commonly used in both otolaryngology to assess vestibular function and neurology to test brain stem function
Study: NCT04680078

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Placement of three interrupted sutures after Triangular Three-snip Punctoplasty of the lower punctum
Description: A Nettelship dilator is used to enlarge the stenotic lacrimal punctum. A single blade of a small Westcott spring scissor or Vannus scissor is placed within the ampulla of the lacrimal canaliculus, with the remaining blade placed on the conjunctival surface of the posterior aspect of the eyelid. The first vertical snip is made at the vertical canaliculus. The second vertical snip is made from the edge of the first snip to create a flap. The final horizontal snip was made at the base. The triangular flap is removed and three sutures are placed, in an interrupted manner, at the posterior wall of the ampulla using 10-0 nylon. The sutures are removed 1 week after the surgery.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Triangular Three-snip Punctoplasty of the lower punctum
Description: A Nettelship dilator is used to enlarge the stenotic lacrimal punctum. A single blade of a small Westcott spring scissor or Vannus scissor is placed within the ampulla of the lacrimal canaliculus, with the remaining blade placed on the conjunctival surface of the posterior aspect of the eyelid. The first vertical snip is made at the vertical canaliculus. The second vertical snip is made from the edge of the first snip to create a flap. The final horizontal snip was made at the base. The triangular flap is then removed .
Study: NCT02472925

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: MedSignals Pill Box
Description: Pill box will provide feedback to the study team regarding subjects' compliance and provide reminders depending on Arm.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MedSignals Pill Box
Description: Pill box will provide feedback to the study team regarding subjects' compliance and provide reminders depending on Arm.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MedSignals Pill Box
Description: Pill box will provide feedback to the study team regarding subjects' compliance and provide reminders depending on Arm.
Study: NCT03057457

Intervention type: DEVICE
Intervention: NGAL Test
Description: The purpose of this study is to demonstrate that BioPorto Diagnostic's NGAL test is able to assist in determining the risk for acute kidney injury for patients who have been admitted to the intensive care unit.
Study: NCT03195855

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual therapy / joint mobilisations
Description: Manual therapy is a common form of treatment employed usually by physiotherapists, in order to help increase range of motion of a specific joint region by restoring the arthrokinematic accessory gliding and rolling movement that is associated with normal joint movement. The hypothesised mechanism of action for this is that improvements of gliding and rolling will normalise osteokinematic rotation and consequently enable the normalisation of active movements. Another possible mechanism of action of mobilisations includes increasing the extensibility of the noncontractile capsular and ligamentous tissues. The effectiveness of passive accessory gliding techniques to increase joint ROM has been widely explored in the literature; with some studies revealing an increase in ankle dorsiflexion and others no change in ankle dorsiflexion. However, the subjects taking part in these studies were people without diabetes and mostly people with ankle sprains or ankle instability.
Study: NCT03065634

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Return to work and living healthy after head and neck cancer
Description: Return to work and living healthy after head and neck cancer (RELIANCE) is a 2-months group intervention for head and neck cancer patients delivered by a trained psychotherapist and a peer in eight sessions. The individual sessions aim to improve work ability, quality of life and psychological well-being

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: socio-legal counseling
Description: Non-manualized socio-legal counseling~two socio-legal counseling sessions delivered by a social worker
Study: NCT04146831

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: Sintilimab: intravenous, 200mg, every 3 week. Course of treatment: Stop the treatment until clinical or radiographic progression occurs.
Study: NCT02336516

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azithromycin
Description: ZITHROMAX ® 40mg/ml solution. DCI : Azithromycin . Pfizer ® 20mg/kg dose with a maximum dose of 500mg per day for three days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (glucose solution 10%)
Study: NCT02389101

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 68Ga-DOTANOC PET/CT; Diffusion weighted MRI
Description: PET/CT: Radionuclide imaging using short-lived isotope Ga-68; MRI imaging w/o gadolinium contrast
Study: NCT02087384

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Gardasil
Description: Intramuscular Gardasil vaccination at 0, 2 and 6 months.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: injection of 0.9% saline
Study: NCT00920894

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: plant stanol ester
Description: the effect of plant stanol esters on plasma lipids
Study: NCT01752582

Intervention type: DEVICE
Group type: OTHER
Intervention: BuMA stent
Description: About 35 patients will undergoing implantation of BuMA stent and receive 6 months dual antiplatelet therapy.

Intervention type: DEVICE
Group type: OTHER
Intervention: EXCEL stent
Description: About 35 patients will undergoing implantation of EXCEL stent and receive 6 months dual antiplatelet therapy.
Study: NCT01987167

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACTHAR
Description: Injectable Gel
Study: NCT04705558

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: continuous moderate intensity aerobic training
Description: continuous moderate intensity aerobic exercises with ketogenic diet group underwent supervised moderate-intensity exercised on a treadmill at 50%-70% of heart rate reserve for three month

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ketogenic diet
Description: Ketogenic diet: a low carbohydrate high-fat diet consisted of the following nutrient conformation: 80% fat, 15% protein and 5% carbohydrates, entire daily intake was estimated to be 20-30 g of carbohydrates for three month.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ketogenic diet
Description: Ketogenic diet: a low carbohydrate high-fat diet consisted of the following nutrient conformation: 80% fat, 15% protein and 5% carbohydrates, entire daily intake was estimated to be 20-30 g of carbohydrates for three month.
Study: NCT04507867

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nutritional support system (NSS)
Description: 1. Combination of three B vitamins (B1, B6 and B12) Neurobion 10 mg solution for IM injection, One every 24 hours for the first 5 days.~2. Probiotics Saccharomyces boulardii CNCM I-745 Floratil. One morning and one evening 250 mg capsule during the first 6 days~3. One envelope of NSS-1 in the morning and one envelope in the afternoon mixed with 400 ml of water each, contain nutritional support system.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional nutritional support designed by hospital nutritionists
Description: Diet designed by the nutrition department according to comorbidities and intubation probability. Food will be established according to the provisions of the ISSEMYM Toluca Arturo Montiel Rojas Medical Center.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Conventional nutritional support designed by hospital nutritionists
Description: Diet designed by the nutrition department according to comorbidities and intubation probability. Food will be established according to the provisions of the ISSEMYM Toluca Arturo Montiel Rojas Medical Center.
Study: NCT03128216

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Blind Local Anesthetic infiltration
Description: Patients of this group received blind local anesthetic infiltration on surgical site. Local anesthetic infiltration are performed by surgeon.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transversals Fascia Block
Description: Patients of this group received ultrasound guided omolateral Transversals Fascia Block.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Spinal Anesthesia
Description: Patients of this group received Spinal Anesthesia

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine
Description: Local anesthetic used for local infiltration and Transversals fascia block

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine
Description: Local anesthetic used for local infiltration and Transversals fascia block

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine
Description: Local anesthetic used for Spinal Anesthesia
Study: NCT00920894

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: plant stanol ester
Description: the effect of plant stanol esters on plasma lipids
Study: NCT01680874

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic
Description: The intervention will consist of the subject taking the study medication once a day for 4 weeks. During hospitalization, patients will be followed daily for diarrhea history, record of concomitant medications, adverse effects (AEs), and their response to treatment using a stool diary. Upon discharge from the hospital, patients will be contacted through weekly phone calls to assess diarrhea history, record of concomitant medications, adverse effects (AEs), and their response to treatment using a stool diary. At weeks 4 and 8, a stool sample will be collected, and the stool diary will be reviewed.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The intervention will consist of the subject taking the placebo once a day for 4 weeks. day for 4 weeks. During hospitalization, patients will be followed daily for diarrhea history, record of concomitant medications, adverse effects (AEs), and their response to treatment using a stool diary. Upon discharge from the hospital, patients will be contacted through weekly phone calls to assess diarrhea history, record of concomitant medications, adverse effects (AEs), and their response to treatment using a stool diary. At weeks 4 and 8, a stool sample will be collected, and the stool diary will be reviewed.
Study: NCT01094028

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxytocin
Description: 20 IU of oxytocin diluted with 26 ml of saline.The medication was injected directly in the umbilical vein after clamping. The injection was performed with a 30-ml syringe and an 18-gauge needle around 1 to 2 cm from the introitus. The solution was injected slowly over 1 minute, and at the end of the injection, the solution was milked toward the cord insertion
Study: NCT04012372

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ROSA Water
Description: Ad libitum hydration with ROSA oligomineral water

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control water
Description: Ad libitum hydration with other waters
Study: NCT02572349

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IW-1701

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Matching Placebo
Study: NCT00932282

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Peanut Oral Immunotherapy
Description: Peanut flour taken by mouth, given every day. Dose ranges from 0.2mg of peanut flour to 8000mg of peanut flour during the maintenance phase.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Peanut Oral Immunotherapy
Description: Peanut flour taken by mouth, given every day. Dose ranges from 0.2mg of peanut flour to 8000mg of peanut flour during the maintenance phase.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Omalizumab
Description: Omalizumab (anti-IgE) will be given for 4 months prior to starting oral immunotherapy. The medication is given as a subcutaneous injection with dose based on total IgE levels and weight at the beginning of the study. This medication is given for a total of 10 months.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Omalizumab
Description: Omalizumab (anti-IgE) will be given for 4 months prior to starting oral immunotherapy. The medication is given as a subcutaneous injection with dose based on total IgE levels and weight at the beginning of the study. This medication is given for a total of 10 months.
Study: NCT01706016

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Thermic destruction of tissue by Laser using the Novilase device
Study: NCT01473576

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nitrate
Description: 0.15 mmol/kg body weight sodium nitrate (dissolved in 250 mL water)

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Sodium chloride
Description: 0.15 mmol sodium chloride dissolved in 250 mL water.
Study: NCT01914523

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Macintosh
Description: Laryngeal exposure and tracheal intubation using that device

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: King Vision
Description: Laryngeal exposure and tracheal intubation using that device

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Glidescope
Description: Laryngeal exposure and tracheal intubation using that device

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: AirTraq
Description: Laryngeal exposure and tracheal intubation using that device
Study: NCT04851275

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physicians trained in shared decision making
Description: Physicians in this group were trained in shared decision making

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physicians were not trained in shared decision making
Description: Physicians did not receive training in shared decision making
Study: NCT01645202

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transcatheter Aortic Valve Implantation (TAVI)
Description: Comparison of different types of valves

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transcatheter Aortic Valve Implantation (TAVI)
Description: Comparison of different types of valves
Study: NCT04400825

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry needling
Description: Dry needling of the active MTrPs following the technique described by Hong et al (1994,1995)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dry needling
Description: Dry needling of the active MTrPs following the technique described by Hong et al (1994,1995)
Study: NCT03209635

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 4 capsules (300 mg/capsule) containing 52% crystalline cellulose and 46% lactose in identical-looking with test product

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic
Description: 4 capsules (300 mg/capsule) containing each capsule 1.0 x 10\^10 colony-forming units (cfu) of Weissella cibaria JW15, twice a day
Study: NCT03235869

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: Durvalumab 1500mg IV over 1 hour administered within 2-7 days of initiation of radiation, then every 28 days.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Radiation to 1-3 cutaneous tumors: 20 Gy (4 Gy x 5 fractions)
Study: NCT01320020

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: catumaxomab
Description: Inter patient dose escalation 2 µg, 4 µg, 7 µg, 10 µg, 14 µg and 19 µg qwk corresponding to dose increments of 100%, 75%, 43%, 40% and 36% respectively of the previous dose
Study: NCT04119219

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intravitreal injection
Description: Intravitreal injection to the regimen pro re nata.
Study: NCT02555566

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Blood sampling
Description: Blood sampling is done for Kidney transplant recipients for evaluation of the polymorphisms and EETs dosage

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: flow-mediated distal stimulation of the forearm radial artery by cutaneous heating
Description: Flow-mediated distal stimulation of the forearm radial artery by cutaneous heating for Kidney transplant recipients
Study: NCT02857335

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: neurocognitive tests
Description: Subjects will undergoe a battery of neurocognitive testing which will test memory, flexible thought process, problem, attention span
Study: NCT02607358

Intervention type: OTHER
Intervention: blood sampling for HOTPR-testing
Description: All subjects are tested for responderstatus using the VerifyNow System

Intervention type: OTHER
Intervention: blood sampling for HOTPR-testing
Description: All subjects are tested for responderstatus using the VerifyNow System
Study: NCT01869166

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CART-EGFR
Study: NCT04058054

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: KeraStat® Cream
Description: Administered 0.025 gm of KeraStat Cream per subject on day 1 of the study.
Study: NCT04834921

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ultraflux® EMiC®2
Description: Ultraflux® EMiC®2-CVVHD runs in septic shock patients with AKI KDIGO 3 for 24 hours. and patients were randomised to start Ultraflux® EMiC®2-CVVHD in the first day or in the second day from the RRT start; more precisely, crossover randomized to sequence consists in Ultraflux® EMiC®2-CVVHD (first day)+ HFF-CVVHDF(second day) and HFF-CVVHDF (first day) + Ultraflux® EMiC®2-CVVHD (second day) for 48 h total without washout

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultraflux® EMiC®2
Description: Ultraflux® EMiC®2-CVVHD runs in septic shock patients with AKI KDIGO 3 for 24 hours. and patients were randomised to start Ultraflux® EMiC®2-CVVHD in the first day or in the second day from the RRT start; more precisely, crossover randomized to sequence consists in Ultraflux® EMiC®2-CVVHD (first day)+ HFF-CVVHDF(second day) and HFF-CVVHDF (first day) + Ultraflux® EMiC®2-CVVHD (second day) for 48 h total without washout